VeriMomIst palmitoyl tripeptide-56 in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
Pregnancy-safe products containing palmitoyl tripeptide-56
Related ingredients
Frequently asked questions
- Ist palmitoyl tripeptide-56 in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
- Ist palmitoyl tripeptide-56 während des Stillens sicher?
- No evidence of reproductive or lactation-specific toxicity; no mechanistic data indicating transfer into breastmilk. Given low expected systemic exposure after topical use, systemic levels are likely minimal but not zero, so exposure is low/measurable. Sources: PubMed (no relevant studies), ECHA (no harmonised classification), PubChem/CosIng (ingredient identity/uses).
- Ist palmitoyl tripeptide-56 sicher für Babyhaut?
- No infant‑specific toxicity or developmental effects reported. Per guidance, infant skin has higher per‑kg exposure and a less mature barrier; for an ingredient with low but measurable adult absorption (e=1), increase exposure score by +1 for babies (e=2). No data support increased hazard or specific mechanisms in infants. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient info).
- Wie bewertet VeriMom palmitoyl tripeptide-56?
- VeriMom bewertet palmitoyl tripeptide-56 mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu palmitoyl tripeptide-56?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu palmitoyl tripeptide-56 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.